FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2130229071> ?p ?o ?g. }

• W2130229071 endingPage "187" @default.
• W2130229071 startingPage "183" @default.
• W2130229071 abstract "Since late 1990s, many molecular target agents have been introduced to clinical trials for various kinds of tumors, and some of them showing significant benefits have been approved. However, these global trials were mainly conducted outside Japan, and the ‘drag lag’ has been a serious problem in Japan recently. Nowadays, Japanese institutions have been participating in some global trials, and the drug lags are getting shorter. For colorectal cancer, molecular target agents such as bevacizumab and cetuximab have been approved in Japan, resulting in improved clinical outcomes. For gastric cancer, Japanese institutions not only contribute to the global Phase III trials of trastuzumab and bevacizumab but also show leadership in the early development of other new agents. For pancreatic cancer, only erlotinib has shown a survival benefit in these 10 years. Worldwide approach including Japan is warranted to achieve better clinical outcomes. For liver cancer, although Japanese institutions did not participate even in the Asian trial of sorafenib, it has been approved in Japan. For esophageal cancer, because there has been no new molecular target agents developed by pharmaceutical companies, investigator-initiated registration trial will play an important role. For all gastrointestinal malignancies, molecular target agents have made a progress in their treatments. In the near future, Japanese institutions will participate in more and more global trials and should play a specific role in worldwide drug development. Furthermore, the optimal use of these new drugs, molecular target agents, based on the daily practice should also be explored in Japan." @default.
• W2130229071 created "2016-06-24" @default.
• W2130229071 creator A5010090426 @default.
• W2130229071 date "2010-01-04" @default.
• W2130229071 modified "2023-10-16" @default.
• W2130229071 title "Current Status and Problems in Development of Molecular Target Agents for Gastrointestinal Malignancy in Japan" @default.
• W2130229071 cites W1931508686 @default.
• W2130229071 cites W1971837077 @default.
• W2130229071 cites W1972107936 @default.
• W2130229071 cites W1994193851 @default.
• W2130229071 cites W1995328364 @default.
• W2130229071 cites W2018048717 @default.
• W2130229071 cites W2048881023 @default.
• W2130229071 cites W2068219429 @default.
• W2130229071 cites W2095201384 @default.
• W2130229071 cites W2097121246 @default.
• W2130229071 cites W2114024312 @default.
• W2130229071 cites W2115351494 @default.
• W2130229071 cites W2125447919 @default.
• W2130229071 cites W2128403792 @default.
• W2130229071 cites W2140625837 @default.
• W2130229071 cites W2143743735 @default.
• W2130229071 cites W2144425748 @default.
• W2130229071 cites W2146434000 @default.
• W2130229071 cites W2156700619 @default.
• W2130229071 cites W2157769714 @default.
• W2130229071 cites W2158134441 @default.
• W2130229071 cites W2166771275 @default.
• W2130229071 cites W2171075804 @default.
• W2130229071 cites W2171932806 @default.
• W2130229071 cites W2314927739 @default.
• W2130229071 cites W2409420104 @default.
• W2130229071 doi "https://doi.org/10.1093/jjco/hyp171" @default.
• W2130229071 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20047861" @default.
• W2130229071 hasPublicationYear "2010" @default.
• W2130229071 type Work @default.
• W2130229071 sameAs 2130229071 @default.
• W2130229071 citedByCount "3" @default.
• W2130229071 countsByYear W21302290712012 @default.
• W2130229071 countsByYear W21302290712014 @default.
• W2130229071 countsByYear W21302290712015 @default.
• W2130229071 crossrefType "journal-article" @default.
• W2130229071 hasAuthorship W2130229071A5010090426 @default.
• W2130229071 hasBestOaLocation W21302290711 @default.
• W2130229071 hasConcept C121608353 @default.
• W2130229071 hasConcept C126322002 @default.
• W2130229071 hasConcept C143998085 @default.
• W2130229071 hasConcept C177713679 @default.
• W2130229071 hasConcept C2776694085 @default.
• W2130229071 hasConcept C2777802072 @default.
• W2130229071 hasConcept C2778019345 @default.
• W2130229071 hasConcept C2778087573 @default.
• W2130229071 hasConcept C2778695046 @default.
• W2130229071 hasConcept C2779438470 @default.
• W2130229071 hasConcept C2779786085 @default.
• W2130229071 hasConcept C2779998722 @default.
• W2130229071 hasConcept C2780035454 @default.
• W2130229071 hasConcept C526805850 @default.
• W2130229071 hasConcept C530470458 @default.
• W2130229071 hasConcept C535046627 @default.
• W2130229071 hasConcept C64903051 @default.
• W2130229071 hasConcept C71924100 @default.
• W2130229071 hasConcept C98274493 @default.
• W2130229071 hasConceptScore W2130229071C121608353 @default.
• W2130229071 hasConceptScore W2130229071C126322002 @default.
• W2130229071 hasConceptScore W2130229071C143998085 @default.
• W2130229071 hasConceptScore W2130229071C177713679 @default.
• W2130229071 hasConceptScore W2130229071C2776694085 @default.
• W2130229071 hasConceptScore W2130229071C2777802072 @default.
• W2130229071 hasConceptScore W2130229071C2778019345 @default.
• W2130229071 hasConceptScore W2130229071C2778087573 @default.
• W2130229071 hasConceptScore W2130229071C2778695046 @default.
• W2130229071 hasConceptScore W2130229071C2779438470 @default.
• W2130229071 hasConceptScore W2130229071C2779786085 @default.
• W2130229071 hasConceptScore W2130229071C2779998722 @default.
• W2130229071 hasConceptScore W2130229071C2780035454 @default.
• W2130229071 hasConceptScore W2130229071C526805850 @default.
• W2130229071 hasConceptScore W2130229071C530470458 @default.
• W2130229071 hasConceptScore W2130229071C535046627 @default.
• W2130229071 hasConceptScore W2130229071C64903051 @default.
• W2130229071 hasConceptScore W2130229071C71924100 @default.
• W2130229071 hasConceptScore W2130229071C98274493 @default.
• W2130229071 hasIssue "3" @default.
• W2130229071 hasLocation W21302290711 @default.
• W2130229071 hasLocation W21302290712 @default.
• W2130229071 hasOpenAccess W2130229071 @default.
• W2130229071 hasPrimaryLocation W21302290711 @default.
• W2130229071 hasRelatedWork W120302965 @default.
• W2130229071 hasRelatedWork W121706947 @default.
• W2130229071 hasRelatedWork W1976155116 @default.
• W2130229071 hasRelatedWork W1983764841 @default.
• W2130229071 hasRelatedWork W2063123552 @default.
• W2130229071 hasRelatedWork W2130229071 @default.
• W2130229071 hasRelatedWork W2130826859 @default.
• W2130229071 hasRelatedWork W2376248794 @default.
• W2130229071 hasRelatedWork W2509427087 @default.
• W2130229071 hasRelatedWork W2509489003 @default.
• W2130229071 hasVolume "40" @default.

• next